Amino.Desk

LL-37 (cathelicidin)

Updated Nov 17, 2026 · Clinical review: pending

LL-37 is an antimicrobial peptide the body makes itself, part of the skin's first line of defense. It has been tested in people only as a topical treatment for leg ulcers, with mixed results. It is sold online as an injection, which has never been studied.

What it is

LL-37 is the only human cathelicidin, a family of peptides that kill bacteria and help coordinate wound repair. Chronic wounds tend to have low levels of it, which is the reasoning behind applying it directly.

What the evidence shows

Both trials put LL-37 on the wound. No human trial has tested it as an injection, for immune support, or for anything else it is sold for.

Dosing

No dose established. The only human dosing is topical concentrations applied to ulcers in clinical trials. Nothing in that work tells you what an injected dose would do.

Legal status

In April 2026 the FDA took LL-37 off its list of substances flagged as significant safety risks for compounding. That is not permission to compound it. An FDA advisory committee is scheduled to review it, with GHK-Cu, dihexa, Melanotan II and PEG-MGF, before the end of February 2027.

Common questions

Has LL-37 been tested in people?

Only as a topical treatment for leg ulcers, with mixed results. A 2014 trial in 34 people found faster healing at lower strengths. A larger 2021 trial in 148 people found no significant improvement over placebo.

Can pharmacies compound LL-37?

Not currently. Its April 2026 removal from the FDA's safety-risk list is not permission to compound it. An advisory committee is scheduled to review it before the end of February 2027.

Is there a dose for injected LL-37?

No. No human trial has tested LL-37 as an injection.

Added in the latest update. These answers summarize the sections above; sources are listed below.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy